"Advertising: McAdams Forms Division to Focus on Latest Drugs"

Important note: Information in this article was accurate in 1991. The state of the art may have changed since the publication date.

"Advertising: McAdams Forms Division to Focus on Latest Drugs"

New York Times (12/16/91), P. D9
Elliott, Stuart

Abstract: A health-care advertising firm is developing a new division to promote some of the newest high-technology drugs. The Helix division of William Douglas McAdams Inc., a New York agency that is designated to promote health-care, will specialize in biotechnology drug treatments. Helix is beginning with five clients: Amgen, Astra Pharmaceutical Products, MGI Pharma, the Roche Laboratories division of Hoffman-La Roche, and Synergen Inc. Helix will deal with 11 products designed to fight infection that is both AIDS-related and otherwise, in addition to cancer, heart disease, and arthritis. One of the AIDS drugs it will be handling is Foscavir, an Astra drug developed to fight AIDS-related CMV retinitis. Helix is unique because it is aimed at communicating with constituencies that pharmaceutical advertising usually does not address, such as ACT-UP.

911216
AD912229

Copyright © 1991 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 1991. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1991. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.